News Sentiment

2616 sentiment intelligence

CStone Pharmaceuticals news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 53 Balanced news tone 5 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 5.28 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.6% over one week, +13.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

CStone Pharmaceuticals (SEHK:2616) Expands Sugemalimab Reach As Valuation Questions Linger

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction -2.6% Price reacting lower
Trend fit Trend inactive 13.1% over four weeks
Fair value 39.6% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 2
富途牛牛 1
Moomoo 1
TradingView 1

Event Lens

What the news is about

Classified themes
Market update 5

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5